Ainos, Inc. (AIMD) Stock

Technology · Scientific & Technical Instruments · Member of Other US Stocks

Ainos, Inc. (AIMD) closed at USD 0.96 on 2026-10-15, a change of -73.6 % over the past year, with a market capitalization of USD 6.82M.

Ainos, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Ainos, Inc. key figures

Previous close

USD 0.96 (2026-10-15)

1-year change

-73.6 %

Market cap

USD 6.82M

Enterprise value

USD 19.21M

P/E ratio (trailing)

-0.36

P/E ratio (forward)

n/a

EPS (trailing)

-2.54

EPS (forward)

n/a

PEG ratio

0.93

Price to book

2.08

Revenue growth

-96.7 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.13

Employees

41

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Ainos, Inc.

Ainos, Inc., a dual-platform company, focusing artificial intelligence–based smelltech technologies and immune therapeutics. It offers AI Nose, an AI-based electronic olfaction system, which uses a smell language model to digitize scent into Smell IDs and turning into machine-readable data. The company provides its platforms for semiconductor manufacturing, robotics, and smart manufacturing industries; as well as senior care and women's health sectors. In addition, it develops VELDONA, a low-dose oral interferon platform for human and animal health applications, targeting rare, autoimmune, and infectious diseases. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in Houston, Texas. Ainos, Inc. is a subsidiary of Taiwan Carbon Nano Technology Corporation.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Ainos, Inc. and compare it with other stocks.